
Saturday, March 16, 2024 2:51:01 AM
Recent GSOL News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 06/13/2025 08:33:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2025 08:34:47 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/05/2025 08:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/02/2025 09:26:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/01/2025 08:58:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/30/2025 09:29:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/29/2025 08:25:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/28/2025 08:58:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/25/2025 08:45:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/24/2025 10:20:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/24/2025 09:06:02 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/04/2025 12:33:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/28/2025 11:39:53 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 01/03/2025 10:18:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/24/2024 09:52:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/07/2024 09:24:23 PM
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • BLEG • Jul 14, 2025 1:23 PM
VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM